𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease

✍ Scribed by Eugeni Domènech; Sílvia Carrión; Esther Garcia-Planella; Míriam Mañosa; Jordi Gordillo; Mar Concepción; Carlos Guarner; Eduard Cabré

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
99 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

The influence of smoking on inflammatory bowel disease (IBD) susceptibility and on its clinical course is well known, but not its impact on drug efficacy. The aim of this study was to evaluate the response to thiopurines in patients with steroid-dependent IBD according to their smoking habits.

Methods:

The medical records of 163 IBD patients (103 Crohn's disease [CD], 60 ulcerative colitis [UC]) in whom thiopurines were started because of steroid-dependency were reviewed. Therapeutic response was defined by steroid-free clinical remission for at least 6 months after 12 months of starting thiopurines. Clinical data and smoking status at diagnosis, at the time thiopurines were started, and during the follow-up were registered.

Results: A therapeutic response was obtained in 72% of CD and 61% of UC patients. Smoking habits did not influence the rate of response to thiopurines, the need for rescue therapies, or the development of penetrating/stricturing complications (CD) or proximal progression (UC). However, CD responders who continued smoking required new courses of steroids more often during follow-up. No influence of smoking was found when these outcomes were analyzed depending on gender or disease location. In the multivariate analysis, smoking status was the only predictive factor of drug tolerance.

Conclusions: Active smoking does not influence the response to thiopurines in steroid-dependent IBD, but may decrease the likelihood of drug tolerance.

📜 SIMILAR VOLUMES

Normal response to vaccines in inflammat
Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines
✍ Iris Dotan; Lael Werner; Sharon Vigodman; Shradha Agarwal; Jorge Pfeffer; Noya H 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

Background: Thiopurines are considered immunosuppressive agents and may be associated with an increased risk for infections. However, few inflammatory bowel disease (IBD) patients are appropriately vaccinated, and data on their ability to mount an immune response are vague. We evaluated the effects

Short-term response to adalimumab in chi
Short-term response to adalimumab in childhood inflammatory bowel disease
✍ Joshua D. Noe; Marian Pfefferkorn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Background: Adalimumab is effective for adults with moderate to severe crohn's disease (cd). data in children with inflammatory bowel disease (ibd) is sparse. we aim to evaluate pediatric ibd response to adalimumab. ## Methods: We conducted a retrospective chart review of pediatric ibd patient

Steroid dependency and pediatric inflamm
Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators—A population-based study
✍ Christian Jakobsen; Pia Munkholm; Anders Paerregaard; Vibeke Wewer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 2 views

## Background: The aim was to investigate the impact of systemic steroid treatment (SST) and immunomodulators (IM) on disease course in children with inflammatory bowel disease (IBD). ## Methods : All IBD patients in eastern Denmark <15 years of age diagnosed in the period 1998-2006 starting th

Active and passive smoking in childhood
Active and passive smoking in childhood is related to the development of inflammatory bowel disease
✍ Suhal S. Mahid; Kyle S. Minor; Arnold J. Stromberg; Susan Galandiuk 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Background: The highest prevalence of smoking in the united states is in kentucky, where smoking typically begins in childhood. the state has many patients who suffer from inflammatory bowel diseases (ibd). the primary aim of this study was to assess whether exposure to active and/or passive tob

Hypoxanthine guanine phosphoribosyltrans
Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease
✍ Liang Ding; Fang-bin Zhang; Hui Liu; Xiang Gao; Hui-chang Bi; Xue-ding Wang; Bai 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Background: Thiopurine drugs are widely used in the treatment of inflammatory bowel disease (IBD). The polymorphic enzyme thiopurine S-methyltransferase (TPMT) is of importance for thiopurine metabolism and adverse events occurrence. The role of other thiopurine-metabolizing enzymes is less well kno